AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India Limited has submitted a certificate dated July 3, 2025, issued by its Registrar and Transfer Agent (Integrated Registry Management Services Private Limited), confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This regulation pertains to the confirmation of dematerialisation of physical shares into demat accounts. The certificate was forwarded to both BSE and NSE on July 15, 2025, and signed by the Company Secretary, Manasa R. This is a standard periodic compliance filing with no business or operational details disclosed.
This is a routine regulatory compliance filing and has no material impact on the company's financials, operations, or share price. Shareholders do not need to take any action.